HERBALIFE LTD. Proceeds from Long-term Lines of Credit
HERBALIFE LTD. (HLF) reported Proceeds from Long-term Lines of Credit of $1.42 billion for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-18.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2026-02-18
- HERBALIFE LTD. proceeds from long-term lines of credit for the quarter ending 2024-12-31 was $276.70M.
- HERBALIFE LTD. proceeds from long-term lines of credit for the quarter ending 2024-09-30 was $156.00M.
- HERBALIFE LTD. proceeds from long-term lines of credit for the quarter ending 2012-12-31 was $43.00M.
- HERBALIFE LTD. proceeds from long-term lines of credit for the quarter ending 2012-09-30 was $581.00M, a 44.89% increase year-over-year.
- HERBALIFE LTD. proceeds from long-term lines of credit for fiscal 2024 was $1.42B.
- HERBALIFE LTD. proceeds from long-term lines of credit for fiscal 2012 was $1.43B.
- HERBALIFE LTD. proceeds from long-term lines of credit for fiscal 2010 was $427.00M, a 101.42% increase from fiscal 2009.
- HERBALIFE LTD. proceeds from long-term lines of credit for fiscal 2009 was $212.00M, a 79.66% increase from fiscal 2008.
| Period end | Proceeds from Long-term Lines of Credit 3 month | Proceeds from Long-term Lines of Credit 6 month | Proceeds from Long-term Lines of Credit 9 month | Proceeds from Long-term Lines of Credit 12 month | Proceeds from Long-term Lines of Credit 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $276.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $432.70M derived: sum of 2 quarters · filed 2026-02-18 | $1.42B 10-K · filed 2026-02-18 | ||
| 2024-09-30 | $156.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.14B 10-Q · filed 2025-11-05 | |||
| 2024-06-30 | $988.50M 10-Q · filed 2025-08-06 | ||||
| 2021-09-30 | $531.20M 10-Q · filed 2022-10-31 | ||||
| 2012-12-31 | $43.00M derived: 10-K 12 month − 3 quarters · filed 2013-02-19 | $624.00M derived: sum of 2 quarters · filed 2013-02-19 | $1.32B derived: sum of 3 quarters · filed 2013-02-19 | $1.43B 10-K · filed 2013-02-19 | |
| 2012-09-30 | $581.00M 10-Q · filed 2012-10-29 | $1.27B derived: sum of 2 quarters · filed 2012-10-29 | $1.39B derived: sum of 3 quarters · filed 2012-10-29 | ||
| 2012-06-30 | $692.00M 10-Q · filed 2012-10-29 | $804.00M derived: sum of 2 quarters · filed 2012-10-29 | |||
| 2012-03-31 | $112.00M 10-Q · filed 2012-10-29 | ||||
| 2011-09-30 | $401.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $502.00M derived: sum of 2 quarters · filed 2011-10-31 | $791.70M 10-Q · filed 2011-10-31 | $880.70M derived: sum of 4 quarters · filed 2013-02-19 | |
| 2011-06-30 | $101.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $390.70M 10-Q · filed 2011-08-01 | $479.70M derived: sum of 3 quarters · filed 2013-02-19 | $588.70M derived: sum of 4 quarters · filed 2013-02-19 | |
| 2011-03-31 | $289.70M 10-Q · filed 2011-05-02 | $378.70M derived: sum of 2 quarters · filed 2013-02-19 | $487.70M derived: sum of 3 quarters · filed 2013-02-19 | $614.70M derived: sum of 4 quarters · filed 2013-02-19 | |
| 2010-12-31 | $89.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $198.00M derived: sum of 2 quarters · filed 2013-02-19 | $325.00M derived: sum of 3 quarters · filed 2013-02-19 | $427.00M 10-K · filed 2013-02-19 | |
| 2010-09-30 | $109.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $236.00M derived: sum of 2 quarters · filed 2011-10-31 | $338.00M 10-Q · filed 2011-10-31 | $411.03M derived: sum of 4 quarters · filed 2012-04-11 | |
| 2010-06-30 | $127.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $229.00M 10-Q · filed 2011-08-01 | $302.03M derived: sum of 3 quarters · filed 2012-04-11 | $382.00M derived: sum of 4 quarters · filed 2012-04-11 | |
| 2010-03-31 | $102.00M 10-Q · filed 2011-05-02 | $175.03M derived: sum of 2 quarters · filed 2012-04-11 | $255.00M derived: sum of 3 quarters · filed 2012-04-11 | ||
| 2009-12-31 | $73.03M derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-04-11 | $153.00M derived: sum of 2 quarters · filed 2012-04-11 | $212.00M 10-K/A · filed 2012-04-11 | $211.97M 10-K · filed 2011-02-22 | |
| 2009-09-30 | $79.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-01 | $138.97M 10-Q · filed 2010-11-01 | |||
| 2009-06-30 | $59.00M 10-Q · filed 2010-08-02 | ||||
| 2008-12-31 | $118.00M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |